Effects of dexmedetomidine on the deformability of erythrocytes in vitro and in anesthesia

  • Authors:
    • Xiao-Ming Yang
    • Jun Liu
    • Jun Ji
    • Jie Xie
  • View Affiliations

  • Published online on: March 27, 2014     https://doi.org/10.3892/etm.2014.1633
  • Pages: 1631-1634
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The current study aimed to evaluate the impact of clinically relevant concentrations of dexmedetomidine on the deformability of erythrocytes in vitro and the effects of dexmedetomidine on the deformability of erythrocytes in patients undergoing laparoscopic cholecystectomy. Erythrocyte suspensions of different concentrations were divided into six groups: Control (group C); low, medium and high concentrations of dexmedetomidine (groups DL, DM and DH, respectively); yohimbine alone (group Y) and yohimbine mixed with dexmedetomidine (group YD). The suspensions were incubated in a thermostatic shaking incubator (50 rpm, 37˚C) for 60 min. The nitric oxide (NO) concentrations and endothelial nitric oxide synthase (eNOS) activities of red blood cells and the erythrocyte deformability index (EI) were then measured. Patients (n=40) scheduled for laparoscopic cholecystectomy were randomly divided into a dexmedetomidine group (group A) and a control group (group B). The induction and maintenance of anesthesia in the two groups was identical. The EI and hematocrit (Hct) were assayed prior to anesthesia (T0) and following the surgery (T1). In the in vitro assay, the EI, the activity of eNOS and the NO concentration of the erythrocytes were significantly higher in groups DL, DM, DH and YD than in group C (P<0.05). In addition, the EI, the eNOS activity and NO concentration of the erythrocytes were higher in group DM than in group YD (P<0.05). In the patients, the EI value at T1 (0.90±0.04) was higher than at T0 (0.81±0.06) in group B (P<0.05). No statistically significant difference between the EI values at T0 and T1 was identified in group A (P>0.05). Dexmedetomidine treatment is able to improve the deformability of erythrocytes in vitro and in anesthesia. The improvement of erythrocyte deformability by dexmedetomidine may be partially associated with adrenergic receptors through activation of eNOS to enhance the concentration of NO in red blood cells.
View References

Related Articles

Journal Cover

June-2014
Volume 7 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang X, Liu J, Ji J and Xie J: Effects of dexmedetomidine on the deformability of erythrocytes in vitro and in anesthesia. Exp Ther Med 7: 1631-1634, 2014
APA
Yang, X., Liu, J., Ji, J., & Xie, J. (2014). Effects of dexmedetomidine on the deformability of erythrocytes in vitro and in anesthesia. Experimental and Therapeutic Medicine, 7, 1631-1634. https://doi.org/10.3892/etm.2014.1633
MLA
Yang, X., Liu, J., Ji, J., Xie, J."Effects of dexmedetomidine on the deformability of erythrocytes in vitro and in anesthesia". Experimental and Therapeutic Medicine 7.6 (2014): 1631-1634.
Chicago
Yang, X., Liu, J., Ji, J., Xie, J."Effects of dexmedetomidine on the deformability of erythrocytes in vitro and in anesthesia". Experimental and Therapeutic Medicine 7, no. 6 (2014): 1631-1634. https://doi.org/10.3892/etm.2014.1633